DOI: 10.1055/s-00000142

Frauenheilkunde up2date

References

Gnant M, Steger G, Greil R. et al.
A prospective randomized multi-center phase-III trial of additional 2 versus additional 5 years of anastrozole after initial 5 years of adjuvant endocrine therapy – results from 3,484 postmenopausal women in the ABCSG-16 trial. 2017 San Antonio Breast Cancer Symposium. San Antonio, TX; Abstr. GS3-01.

Download Bibliographical Data